Royal Bank of Canada’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Royal Bank of Canada’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-102	Closed	–	–	7732
2024 Q2	$0	Sell	102 -71	-41%	-$239	﹤0.01%	7712
2024 Q1	$1K	Sell	173 -874	-83%	-$6.73K	﹤0.01%	6917
2023 Q4	$2K	Buy	1,047 +1,025	+4,659%	+$3.46K	﹤0.01%	6863
2023 Q3	$0	Buy	22 +2	+10%	+$12	﹤0.01%	7769
2023 Q2	$0	Buy	+20	New	+$172	﹤0.01%	7790
2022 Q4	–	Sell	-2	Closed	–	–	7885
2022 Q3	$0	Buy	+2	New	+$59	﹤0.01%	8010
2022 Q2	–	Sell	-52	Closed	-$6K	–	7844
2022 Q1	$6K	Sell	52 -162	-76%	-$11.9K	﹤0.01%	7214
2021 Q4	$25K	Buy	214 +117	+121%	+$28.1K	﹤0.01%	6702
2021 Q3	$36K	Buy	97 +70	+259%	+$23.5K	﹤0.01%	6353
2021 Q2	$12K	Sell	27 -3	-10%	-$1.38K	﹤0.01%	6814
2021 Q1	$14K	Buy	+30	New	+$16.3K	﹤0.01%	6651

Other funds holding NEXI

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada's NEXI Position: Q3 2024 in Review

Royal Bank of Canada sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 102 shares.

Royal Bank of Canada first reported a position in NEXI in Q1 2021 and held it in 11 quarters. The position peaked at $36K in Q3 2021. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

Royal Bank of Canada reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 102 NexImmune, Inc. Common Stock shares in Q3 2024.
Royal Bank of Canada first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Royal Bank of Canada's NexImmune, Inc. Common Stock position peaked at $36K in Q3 2021.
1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.